Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Bittner

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MSFelix Luessi, Sinah Engel, Annette Spreer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2023
Tunable nonlinear optical mapping in a multiple-scattering cavityYaniv Eliezer, Ulrich Rührmair, Nils Wisiol, et al.
Journal of Visualized Experiments : Jove|May 7, 2014
Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 miceStefan Bittner, Ali M Afzali, Heinz Wiendl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 22, 2014
TREK-king the blood-brain-barrierStefan Bittner, Tobias Ruck, Juncal Fernández-Orth, et al.
Journal of Neurology|October 5, 2017
Disease reactivation after switching from natalizumab to daclizumabTimo Uphaus, Christoph Oberwittler, Sergiu Groppa, et al.
Iscience|November 25, 2020
How Repair-or-Dispose Decisions Under Stress Can Initiate Disease ProgressionAndreas Nold, Danylo Batulin, Katharina Birkner, et al.
Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
FEBS Letters|April 20, 2011
Ion channels in autoimmune neurodegenerationPetra Ehling, Stefan Bittner, Thomas Budde, et al.
Brain : a Journal of Neurology|June 28, 2021
The potential of serum neurofilament as biomarker for multiple sclerosisStefan Bittner, Jiwon Oh, Eva Kubala Havrdová, et al.
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Neurology(R) Neuroimmunology & Neuroinflammation|July 21, 2018
GFAPα IgG-associated encephalitis upon daclizumab treatment of MSFelix Luessi, Sinah Engel, Annette Spreer, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 25, 2023
Tunable nonlinear optical mapping in a multiple-scattering cavityYaniv Eliezer, Ulrich Rührmair, Nils Wisiol, et al.
Journal of Visualized Experiments : Jove|May 7, 2014
Myelin oligodendrocyte glycoprotein (MOG35-55) induced experimental autoimmune encephalomyelitis (EAE) in C57BL/6 miceStefan Bittner, Ali M Afzali, Heinz Wiendl, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|February 22, 2014
TREK-king the blood-brain-barrierStefan Bittner, Tobias Ruck, Juncal Fernández-Orth, et al.
Journal of Neurology|October 5, 2017
Disease reactivation after switching from natalizumab to daclizumabTimo Uphaus, Christoph Oberwittler, Sergiu Groppa, et al.
Iscience|November 25, 2020
How Repair-or-Dispose Decisions Under Stress Can Initiate Disease ProgressionAndreas Nold, Danylo Batulin, Katharina Birkner, et al.
Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.
FEBS Letters|April 20, 2011
Ion channels in autoimmune neurodegenerationPetra Ehling, Stefan Bittner, Thomas Budde, et al.
Brain : a Journal of Neurology|June 28, 2021
The potential of serum neurofilament as biomarker for multiple sclerosisStefan Bittner, Jiwon Oh, Eva Kubala Havrdová, et al.
Therapeutic Advances in Neurological Disorders|August 30, 2021
Treatment approaches to patients with multiple sclerosis and coexisting autoimmune disordersTobias Brummer, Tobias Ruck, Sven G Meuth, et al.
Pageof 24